Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using Fludarabine, Reduced-Dose Cyclophosphamide, and ATG
Sumiko Kohashi, Takehiko Mori, Jun Kato, Akiko Yamane, Shinichiro Okamoto
Abstract
Open-access reader
Sumiko Kohashi, Takehiko Mori, Jun Kato, Akiko Yamane, Shinichiro Okamoto
Abstract
Open-access reader
Although allogeneic hematopoietic stem cell transplantation (HSCT) has been widely performed for severe aplastic anemia (SAA), the standard conditioning regimen has yet to be established. Recently, the outcomes of a variety of reduced-intensity conditioning regimens using fludarabine have been reported.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Although allogeneic hematopoietic stem cell transplantation (HSCT) has been widely performed for severe aplastic anemia (SAA), the standard conditioning regimen has yet to be established. Recently, the outcomes of a variety of reduced-intensity conditioning regimens using fludarabine have been reported.
Key concepts: Medicine, Fludarabine, Thymoglobulin, Aplastic anemia, Cyclophosphamide, Transplantation, Hematopoietic stem cell transplantation, Surgery